(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are LUCASBOLS, ULTIMOVACS, and XXL.

Financial Asset	Price	Change	Updated (EST)
LUCASBOLS (BOLS.AS)	17.35	70.1%	2023-10-09 12:02:48
ULTIMOVACS (ULTI.OL)	108.00	10.54%	2023-10-09 12:44:11
XXL (XXL.OL)	0.68	8.7%	2023-10-09 12:44:33
MOTORK (MTRK.AS)	3.00	7.14%	2023-10-09 12:02:58
PGS (PGS.OL)	9.34	6.91%	2023-10-09 12:42:22
TGS (TGS.OL)	145.60	6.51%	2023-10-09 12:44:02
ATEA (ATEA.OL)	136.60	6.39%	2023-10-09 12:24:47
ATENOR (ATEB.BR)	9.80	6.29%	2023-10-09 12:04:58
PETROLIA (PSE.OL)	4.63	5.71%	2023-10-09 12:42:16
KID (KID.OL)	89.20	5.69%	2023-10-09 12:40:50

The three biggest losers today are ZENOBE GRAMME CERT, SAS AB, and AUGROS COSMETICS.

Financial Asset	Price	Change	Updated (EST)
ZENOBE GRAMME CERT (ZEN.BR)	156.00	-18.32%	2023-10-09 12:22:14
SAS AB (SASNO.OL)	0.02	-14.89%	2023-10-09 12:42:52
AUGROS COSMETICS (AUGR.PA)	7.00	-11.39%	2023-10-09 12:46:06
PCI BIOTECH HOLD (PCIB.OL)	1.32	-7.95%	2023-10-09 12:42:14
EUROCASTLE INVEST. (ECT.AS)	7.40	-7.5%	2023-10-09 12:01:56
CELYAD ONCOLOGY (CYAD.BR)	0.73	-6.92%	2023-10-09 12:05:32
ADOCIA (ADOC.PA)	7.02	-6.4%	2023-10-09 12:45:04
AIR FRANCE -KLM (AF.PA)	11.78	-5.52%	2023-10-09 12:45:17
CONTEXTVISION (CONTX.OL)	6.78	-5.31%	2023-10-09 12:25:33
UNIFIEDPOST GROUP (UPG.BR)	2.37	-5.21%	2023-10-09 12:21:58

Winners today

1. LUCASBOLS (BOLS.AS)

70.1% Price Change

Lucas Bols N.V. produces, bottles, markets, distributes, and sells cocktail and spirits. The company offers a range of spirits products, including liqueurs, genever, gin, and vodka under the Bols, Galliano, Passoã, Bokma, Bols Genevers, Coebergh, Damrak, Hartevelt, Henkes, Hoppe, KLM houses, Nuvo, Pallini, Pisang Ambon, Tequila Partida, Vaccari, Wynand Fockink, Fluère, and Zwarte Kip brands. It operates in approximately 110 countries worldwide. The company was founded in 1575 and is headquartered in Amsterdam, the Netherlands.

AEX-Index ended the session with LUCASBOLS jumping 70.1% to €17.35 on Monday, following the last session’s upward trend. AEX-Index dropped 0.1% to €726.00, after three successive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, LUCASBOLS has a trailing twelve months EPS of €-1.09.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.52%.

Volume

Today’s last reported volume for LUCASBOLS is 482081 which is 8345.7% above its average volume of 5708.

Revenue Growth

Year-on-year quarterly revenue growth declined by 4.5%, now sitting on 100.61M for the twelve trailing months.

More news about LUCASBOLS.

2. ULTIMOVACS (ULTI.OL)

10.54% Price Change

Ultimovacs ASA, a biotech company, develops immunotherapies against cancers. Its lead product candidate is UV1, a peptide-based cancer vaccine that induces a specific T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ULTIMOVACS jumping 10.54% to €108.00 on Monday, after four consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 2.31% to €1,280.13, following the last session’s downward trend on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, ULTIMOVACS has a trailing twelve months EPS of kr-5.43.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.11%.

Volume

Today’s last reported volume for ULTIMOVACS is 129936 which is 178.45% above its average volume of 46664.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ULTIMOVACS’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

ULTIMOVACS’s stock is valued at kr108.00 at 22:40 EST, way below its 52-week high of kr142.60 and way higher than its 52-week low of kr58.50.

Moving Average

ULTIMOVACS’s worth is way higher than its 50-day moving average of kr75.42 and above its 200-day moving average of kr104.04.

More news about ULTIMOVACS.

3. XXL (XXL.OL)

8.7% Price Change

XXL ASA operates as a sports retailer. It offers sports equipment and sportswear for various sports, including running, football, golf, water sports, racket sports, and ice hockey; and fitness equipment, including treadmills and rowing machines, as well as food supplements and nutrition. The company also provides clothes for men, women, and children for baselayers, outerwear, casual wear, sportswear, and swimwear, as well as lifestyle shoes and winter shoes; outdoor and hunting products for fishing, wilderness living, and camping, such as tents, lavvos, sleeping bags, backpacks, cooking equipment as well as climbing gear; and hunting products, including firearms and ammunition, clothes, binoculars, optics, knives, and axes. In addition, it offers skis and ski accessories, such as shoes, poles, clothes, and other equipment for cross-country and downhill skiing, as well as snowboarding; high-end and everyday bikes comprising hybrid bikes, mountain bikes, city bikes, and electric bikes for children, women, and men; and bike equipment, such as helmets, shoes, spare parts, and clothes. Further, the company provides products that connect technology and sports/outdoor activities, including sport watches, action cameras, drones, GPS, earplugs and headphones, portable loudspeakers, sunglasses, pulse meters, power banks, and cycle computers. It operates stores in Norway, Sweden, and Finland, as well as e-commerce websites, such as xxl.no, xxl.se, xxl.fi, and xxl.dk. The company was founded in 2000 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with XXL jumping 8.7% to €0.68 on Monday while Oslo Børs Benchmark Index_GI rose 2.31% to €1,280.13.

Earnings Per Share

As for profitability, XXL has a trailing twelve months EPS of kr-1.8.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.05%.

Volatility

XXL’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.04%, a negative 0.46%, and a positive 4.21%.

XXL’s highest amplitude of average volatility was 0.78% (last week), 2.11% (last month), and 4.21% (last quarter).

Volume

Today’s last reported volume for XXL is 2107400 which is 8.47% below its average volume of 2302620.

Yearly Top and Bottom Value

XXL’s stock is valued at kr0.68 at 22:40 EST, way below its 52-week high of kr5.95 and above its 52-week low of kr0.67.

More news about XXL.

4. MOTORK (MTRK.AS)

7.14% Price Change

MotorK plc, together with its subsidiaries, provides software-as-a-service for the automotive retail industry in Italy, Spain, France, and Germany. The company offers a combination of automotive SaaS products and digital solutions to the digital lead generation, management, and nurturing process. It provides technology and software solutions for car manufacturers, dealers, and service centers. The company offers WebSparK, a web platform for traffic acquisition and lead generation performance; LeadSparK, a CRM platform to support the activities of car dealerships and automotive manufacturers; and StockSparK, a stock management platform. The company was incorporated in 2010 and is headquartered in Milan, Italy.

AEX-Index ended the session with MOTORK jumping 7.14% to €3.00 on Monday, after three sequential sessions in a row of gains. AEX-Index dropped 0.1% to €726.00, after three successive sessions in a row of gains, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, MOTORK has a trailing twelve months EPS of €-0.49.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -25.18%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 29.5%, now sitting on 43.54M for the twelve trailing months.

More news about MOTORK.

5. PGS (PGS.OL)

6.91% Price Change

PGS ASA, together with its subsidiaries, operates as a marine geophysical company primarily in Norway. The company provides a range of seismic and reservoir services, including data acquisition, imaging, interpretation, and field evaluation to oil and gas companies, as well as carbon storage and offshore wind markets. It also operates in the Asia Pacific, Canada, Egypt, the Americas, Angola, the United Kingdom, Greece, Cyprus, Ukraine, Brazil, South Africa, other African countries, the Middle East, and internationally. The company was formerly known as Petroleum Geo-Services ASA and changed its name to PGS ASA in May 2019. PGS ASA was founded in 1991 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PGS jumping 6.91% to €9.34 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 2.31% to €1,280.13, following the last session’s downward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, PGS has a trailing twelve months EPS of kr-0.77.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.17%.

More news about PGS.

6. TGS (TGS.OL)

6.51% Price Change

TGS ASA provides geoscience data products and services to the oil and gas industry worldwide. The company offers geophysical data, including multi-client seismic data; geological data comprising well data products, and interpretive studies and services; and interpretation products and data integration solutions. It also provides imaging services, which include depth and time imaging; marine, land, and ocean bottom nodes; and transition zone, multi component, and 4D time-lapse processing. The company was formerly known as TGS-NOPEC Geophysical Company ASA and changed its name to TGS ASA in June 2021. TGS ASA was founded in 1981 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with TGS jumping 6.51% to €145.60 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 2.31% to €1,280.13, following the last session’s downward trend on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, TGS has a trailing twelve months EPS of kr4.95.

PE Ratio

TGS has a trailing twelve months price to earnings ratio of 29.41. Meaning, the purchaser of the share is investing kr29.41 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.74%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jul 27, 2023, the estimated forward annual dividend rate is 5.64 and the estimated forward annual dividend yield is 3.85%.

Volume

Today’s last reported volume for TGS is 1546820 which is 164.86% above its average volume of 584013.

Revenue Growth

Year-on-year quarterly revenue growth declined by 10.3%, now sitting on 733.84M for the twelve trailing months.

More news about TGS.

7. ATEA (ATEA.OL)

6.39% Price Change

Atea ASA provides IT infrastructure and related solutions for businesses and public sector organizations in the Nordic countries and Baltic regions. The company offers hardware and software solutions for storing and managing information, as well as tools for virtualization, automation, and security for operating the data center environment; and client hardware, software, and services to the requirements of users, applications, security, networks, and computing environments. It also provides hardware and software solutions for running networks, and services to help customers manage their communications; and a range of products to enable collaboration through conferencing, information sharing, and digital productivity solutions. In addition, it offers digital workplace solutions that consist of devices and software through which users conducts work, access data and applications, and interact with each other; information management solutions; and IT asset lifecycle management, professional, and managed services. Atea ASA was founded in 1968 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATEA rising 6.39% to €136.60 on Monday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 2.31% to €1,280.13, following the last session’s downward trend on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, ATEA has a trailing twelve months EPS of kr7.72.

PE Ratio

ATEA has a trailing twelve months price to earnings ratio of 17.69. Meaning, the purchaser of the share is investing kr17.69 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.33%.

Yearly Top and Bottom Value

ATEA’s stock is valued at kr136.60 at 22:40 EST, way under its 52-week high of kr166.20 and way above its 52-week low of kr92.00.

More news about ATEA.

8. ATENOR (ATEB.BR)

6.29% Price Change

Atenor SA, a real estate development company, invests in large-scale real estate projects in Belgium, Luxembourg, the Netherlands, France, Germany, Portugal, Poland, Hungary, the United Kingdom, and Romania. The company develops real estate projects, such as offices and residential buildings. Atenor SA was founded in 1910 and is headquartered in La Hulpe, Belgium.

BEL 20 ended the session with ATENOR rising 6.29% to €9.80 on Monday, after two sequential sessions in a row of losses. BEL 20 dropped 0.3% to €3,480.05, after two sequential sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, ATENOR has a trailing twelve months EPS of €-9.45.

Volume

Today’s last reported volume for ATENOR is 8612 which is 55.14% above its average volume of 5551.

More news about ATENOR.

9. PETROLIA (PSE.OL)

5.71% Price Change

Petrolia SE, together with its subsidiaries, sells and rents energy service equipment to energy industry in Norway, rest of Europe, Asia, and Australia. It operates through two segments, Energy and Energy Service. The company engages in the exploration and production of oil and gas, as well as produces hydrogen and ammonia. It also offers drill pipes, test strings and tubing, and other equipment, as well as casing, handling, and auxiliary tools; and equipment inspection and maintenance services. In addition, the company offers casing and tubing running, drilling, and make and brake services. It serves energy companies, drilling contractors, and energy service companies. The company was formerly known as Petrolia E&P Holdings SE and changed its name to Petrolia SE in January 2013. Petrolia SE was founded in 1997 and is based in Limassol, Cyprus.

Oslo Børs Benchmark Index_GI ended the session with PETROLIA rising 5.71% to €4.63 on Monday while Oslo Børs Benchmark Index_GI rose 2.31% to €1,280.13.

Earnings Per Share

As for profitability, PETROLIA has a trailing twelve months EPS of kr0.04.

PE Ratio

PETROLIA has a trailing twelve months price to earnings ratio of 115.75. Meaning, the purchaser of the share is investing kr115.75 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.94%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PETROLIA’s stock is considered to be oversold (<=20).

Moving Average

PETROLIA’s worth is way above its 50-day moving average of kr4.12 and way above its 200-day moving average of kr4.08.

Volume

Today’s last reported volume for PETROLIA is 25134 which is 11.34% above its average volume of 22574.

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.3%, now sitting on 57.99M for the twelve trailing months.

More news about PETROLIA.

10. KID (KID.OL)

5.69% Price Change

Kid ASA, together with its subsidiaries, operates as a home textile retailer in Norway, Sweden, Finland, and Estonia. It designs, sources, markets, and sells a range of home and interior products, including textiles, curtains, bed linens, home accessories, decorations, furniture, and other interior products through retail stores and online platforms. The company provides its products under the Kid, Hemtex, Dekosol, Nordun, and Premium Collection brands. It also offers logistics services. The company was formerly known as Nordisk Tekstil Holding AS and changed its name to Kid ASA. Kid ASA was founded in 1937 and is headquartered in Lier, Norway.

Oslo Børs Benchmark Index_GI ended the session with KID jumping 5.69% to €89.20 on Monday while Oslo Børs Benchmark Index_GI jumped 2.31% to €1,280.13.

Earnings Per Share

As for profitability, KID has a trailing twelve months EPS of kr4.39.

PE Ratio

KID has a trailing twelve months price to earnings ratio of 20.32. Meaning, the purchaser of the share is investing kr20.32 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.71%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 0.8%, now sitting on 3.17B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 45.2% and 25.3%, respectively.

More news about KID.

Losers Today

1. ZENOBE GRAMME CERT (ZEN.BR)

-18.32% Price Change

Immo-Zenobe Gramme SA engages in the issuance of real estate certificates in Belgium. Immo-Zenobe Gramme SA is based in Molenbeek-Saint-Jean, Belgium. Immo-Zenobe Gramme SA operates as a subsidiary of KBC Bank NV.

BEL 20 ended the session with ZENOBE GRAMME CERT dropping 18.32% to €156.00 on Monday while BEL 20 dropped 0.3% to €3,480.05.

Earnings Per Share

As for profitability, ZENOBE GRAMME CERT has a trailing twelve months EPS of €0.18.

PE Ratio

ZENOBE GRAMME CERT has a trailing twelve months price to earnings ratio of 866.67. Meaning, the purchaser of the share is investing €866.67 for every euro of annual earnings.

Moving Average

ZENOBE GRAMME CERT’s worth is way below its 50-day moving average of €194.46 and way below its 200-day moving average of €206.17.

Yearly Top and Bottom Value

ZENOBE GRAMME CERT’s stock is valued at €156.00 at 22:40 EST, way under its 52-week low of €188.00.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ZENOBE GRAMME CERT’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for ZENOBE GRAMME CERT is 1000 which is 11011.1% above its average volume of 9.

More news about ZENOBE GRAMME CERT.

2. SAS AB (SASNO.OL)

-14.89% Price Change

SAS AB (publ), together with its subsidiaries, provides passenger flight transportation services in the Nordic and international route network. The company also offers air cargo services, in-flight sales, ground handling, and technical maintenance services, as well as travel-related loyalty programs. It operates a fleet of 135 aircraft, including 12 long-haul aircraft, 95 short-haul aircraft, and 28 aircraft flown by regional production partners. The company was founded in 1946 and is headquartered in Stockholm, Sweden. On July 5, 2022, SAS AB (publ), along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.

Oslo Børs Benchmark Index_GI ended the session with SAS AB dropping 14.89% to €0.02 on Monday while Oslo Børs Benchmark Index_GI rose 2.31% to €1,280.13.

Earnings Per Share

As for profitability, SAS AB has a trailing twelve months EPS of kr-0.53.

More news about SAS AB.

3. AUGROS COSMETICS (AUGR.PA)

-11.39% Price Change

Augros Cosmetic Packaging SA provides customized packaging solutions in France. The company offers decoration solutions for glass, plastic, and aluminum packaging materials. It serves the perfume, cosmetic, and spirit industries. The company is based in Alencon, France. Augros Cosmetic Packaging SA operates as a subsidiary of Famille Bourgine.

CAC 40 ended the session with AUGROS COSMETICS sliding 11.39% to €7.00 on Monday while CAC 40 dropped 0.55% to €7,021.40.

Earnings Per Share

As for profitability, AUGROS COSMETICS has a trailing twelve months EPS of €0.43.

PE Ratio

AUGROS COSMETICS has a trailing twelve months price to earnings ratio of 16.28. Meaning, the purchaser of the share is investing €16.28 for every euro of annual earnings.

Volatility

AUGROS COSMETICS’s last week, last month’s, and last quarter’s current intraday variation average was 15.33%, 3.84%, and 7.96%.

AUGROS COSMETICS’s highest amplitude of average volatility was 15.33% (last week), 5.29% (last month), and 7.96% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AUGROS COSMETICS’s stock is considered to be oversold (<=20).

More news about AUGROS COSMETICS.

4. PCI BIOTECH HOLD (PCIB.OL)

-7.95% Price Change

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD falling 7.95% to €1.32 on Monday while Oslo Børs Benchmark Index_GI jumped 2.31% to €1,280.13.

Earnings Per Share

As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.78.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -47.54%.

Volume

Today’s last reported volume for PCI BIOTECH HOLD is 49821 which is 69.08% below its average volume of 161159.

Revenue Growth

Year-on-year quarterly revenue growth declined by 84.4%, now sitting on 2.79M for the twelve trailing months.

More news about PCI BIOTECH HOLD.

5. EUROCASTLE INVEST. (ECT.AS)

-7.5% Price Change

Eurocastle Investment Limited is a publicly traded closed-ended investment company that focuses on investing in performing and nonperforming loans and other real estate related assets primarily in Italy. The Company is Euro denominated and is listed on Euronext Amsterdam under the symbol “ECT”. Eurocastle is managed by an affiliate of Fortress Investment Group LLC, a leading global investment manager. For more information regarding Eurocastle Investment Limited and to be added to our email distribution list, please visit www.eurocastleinv.com.

AEX-Index ended the session with EUROCASTLE INVEST. falling 7.5% to €7.40 on Monday, after five successive sessions in a row of losses. AEX-Index dropped 0.1% to €726.00, after three successive sessions in a row of gains, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, EUROCASTLE INVEST. has a trailing twelve months EPS of €-0.68.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.2%.

Moving Average

EUROCASTLE INVEST.’s value is way higher than its 50-day moving average of €6.69 and below its 200-day moving average of €7.76.

More news about EUROCASTLE INVEST..

6. CELYAD ONCOLOGY (CYAD.BR)

-6.92% Price Change

Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical trial to treat relapsed / refractory multiple myeloma; and CYAD-02, an autologous CAR-T candidate that is in Phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery Group plc for the use of its shRNA reagents to reduce expression of one or more defined targets. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with CELYAD ONCOLOGY falling 6.92% to €0.73 on Monday, following the last session’s upward trend. BEL 20 fell 0.3% to €3,480.05, after two successive sessions in a row of gains, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, CELYAD ONCOLOGY has a trailing twelve months EPS of €-1.41.

Volatility

CELYAD ONCOLOGY’s last week, last month’s, and last quarter’s current intraday variation average was 7.10%, 0.36%, and 6.11%.

CELYAD ONCOLOGY’s highest amplitude of average volatility was 12.81% (last week), 8.28% (last month), and 6.11% (last quarter).

Volume

Today’s last reported volume for CELYAD ONCOLOGY is 7214 which is 84.27% below its average volume of 45865.

More news about CELYAD ONCOLOGY.

7. ADOCIA (ADOC.PA)

-6.4% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA dropping 6.4% to €7.02 on Monday, following the last session’s upward trend. CAC 40 slid 0.55% to €7,021.40, after two successive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-2.52.

More news about ADOCIA.

8. AIR FRANCE -KLM (AF.PA)

-5.52% Price Change

Air France-KLM SA, together with its subsidiaries, provides passenger and cargo transportation services and aeronautical maintenance in Metropolitan France, Benelux, rest of Europe, and internationally. The company operates through three segments: Airframe maintenance, Engine Maintenance, and Component Support. It offers airframe maintenance, electronic, mechanical, pneumatic, hydraulic, and other services. The company was founded in 1919 and is headquartered in Paris, France.

CAC 40 ended the session with AIR FRANCE -KLM sliding 5.52% to €11.78 on Monday, after three sequential sessions in a row of gains. CAC 40 dropped 0.55% to €7,021.40, after two successive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, AIR FRANCE -KLM has a trailing twelve months EPS of €8.02.

PE Ratio

AIR FRANCE -KLM has a trailing twelve months price to earnings ratio of 1.47. Meaning, the purchaser of the share is investing €1.47 for every euro of annual earnings.

Yearly Top and Bottom Value

AIR FRANCE -KLM’s stock is valued at €11.78 at 22:40 EST, way above its 52-week high of €1.86.

More news about AIR FRANCE -KLM.

9. CONTEXTVISION (CONTX.OL)

-5.31% Price Change

ContextVision AB (publ), a medical technology software company, provides image analysis and imaging for medical systems in Asia, Europe, and the United States. The company offers image enhancement software for 2D/3D/4D ultrasound, radiography, magnetic resonance imaging (MRI), and veterinary. Its products include Rivent that offers unparalleled image quality for various types of ultrasound systems for women's health, general imaging, cardiovascular, and point of care applications; Rivent Mobile, an enhancing ultrasound image for the handheld ultrasound devices using mobile phones and tablets; and Rivent 3D, an image enhancement product for 3D ultrasound. The company also provides Altumira/Altumira Plus, a platform for digital radiography; and Orthopedic Package for orthopedic imaging. In addition, it offers GOPView MRI2Plus, an image enhancement solution for MRI. The company was founded in 1983 and is headquartered in Stockholm, Sweden.

Oslo Børs Benchmark Index_GI ended the session with CONTEXTVISION dropping 5.31% to €6.78 on Monday while Oslo Børs Benchmark Index_GI jumped 2.31% to €1,280.13.

Earnings Per Share

As for profitability, CONTEXTVISION has a trailing twelve months EPS of kr0.45.

PE Ratio

CONTEXTVISION has a trailing twelve months price to earnings ratio of 15.07. Meaning, the purchaser of the share is investing kr15.07 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 61.1%.

More news about CONTEXTVISION.

10. UNIFIEDPOST GROUP (UPG.BR)

-5.21% Price Change

UnifiedPost Group SA, a fintech company, operates and develops a cloud-based platform for administrative and financial services in Belgium and internationally. Its platform allows connections between its customers, suppliers, customers, and other parties in the financial supply chain. The company offers a technology portfolio for document processing, identity management, payment services, and added value financial services, as well as engages in post and parcel optimization activities. It serves corporate and government customers; small and medium-sized enterprises; and agricultural, accounting, interim, and construction sectors. UnifiedPost Group SA was founded in 2001 and is headquartered in La Hulpe, Belgium.

BEL 20 ended the session with UNIFIEDPOST GROUP sliding 5.21% to €2.37 on Monday, following the last session’s upward trend. BEL 20 slid 0.3% to €3,480.05, after two consecutive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, UNIFIEDPOST GROUP has a trailing twelve months EPS of €-1.34.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -29.78%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, UNIFIEDPOST GROUP’s stock is considered to be oversold (<=20).

Moving Average

UNIFIEDPOST GROUP’s value is way under its 50-day moving average of €3.27 and way below its 200-day moving average of €3.81.

More news about UNIFIEDPOST GROUP.

Stay up to date with our winners and losers daily report